Ackroyd Sarah A, Walls Melinique, Kim Josephine S, Lee Nita K
University of Chicago Medicine, Section of Gynecologic Oncology, 5841 S Maryland Ave, Chicago, IL 60637 USA.
University of Chicago, Pritzker School of Medicine, 5841 S Maryland Ave, Chicago, IL 60637, USA.
Gynecol Oncol Rep. 2022 Apr 27;41:100986. doi: 10.1016/j.gore.2022.100986. eCollection 2022 Jun.
To describe the use of telemedicine in gynecologic oncology and identify patient characteristics associated with telemedicine use during COVID-19.
Single-institution retrospective chart review of patients with gynecologic cancer who participated in in-person and telemedicine visits (video and telephone) from January 2019 to November 2020. Patient characteristics, visit and treatment characteristics were collected. Comparisons between 2019 and 2020 and between in-person and telemedicine visits were performed. Cancer-specific visit details were described.
From January to November 2020, 2,039 patients attended 5240 ambulatory visits in our gynecologic oncology outpatient clinics with 4,304 (82.1%) in-person visits, 512 (9.8%) video telemedicine visits, and 424 (8.1%) telephone visits. In 2020, 936 (45.9%) patients participated in a telemedicine visit. Demographic characteristics did not differ between those who participated in any telemedicine versus in-person visits (p > 0.05). Black patients represented a larger share of telephone visits but this was not significant. Patients aged > 65 years were more likely to use the telephone for a visit and less likely to use video visits compared to their younger counterparts. The majority of patients who attended a telemedicine visit also attended a visit in-person (88.0%). The most common purpose of the telemedicine visits was to discuss results and/or treatment plans (46%) with other appointments occurring for treatment check-ins and clinical trials.
The use of telemedicine drastically increased in 2020. Patient demographics were not different between in-person and telemedicine visits except that older patients were more likely to use telephone visits over video visits. Telemedicine can be used for a variety of care needs in gynecologic oncology but further work needs to be done to optimize implementation, assess cost-effectiveness and patient outcomes.
描述远程医疗在妇科肿瘤学中的应用，并确定在2019冠状病毒病期间与使用远程医疗相关的患者特征。
对2019年1月至2020年11月期间参与面对面就诊和远程医疗就诊（视频和电话）的妇科癌症患者进行单机构回顾性病历审查。收集患者特征、就诊和治疗特征。对2019年和2020年以及面对面就诊和远程医疗就诊之间进行比较。描述特定癌症的就诊细节。
2020年1月至11月，2039名患者在我们的妇科肿瘤门诊进行了5240次门诊就诊，其中面对面就诊4304次（82.1%），视频远程医疗就诊512次（9.8%），电话就诊424次（8.1%）。2020年，936名（45.9%）患者参与了远程医疗就诊。参与任何远程医疗就诊与面对面就诊的患者的人口统计学特征无差异（p>0.05）。黑人患者在电话就诊中所占比例较大，但不显著。与年轻患者相比，65岁以上的患者更有可能通过电话就诊，而通过视频就诊的可能性较小。大多数参加远程医疗就诊的患者也进行了面对面就诊（88.0%）。远程医疗就诊最常见的目的是与其他用于治疗检查和临床试验的预约一起讨论结果和/或治疗计划（46%）。
2020年远程医疗的使用大幅增加。面对面就诊和远程医疗就诊的患者人口统计学特征没有差异，只是老年患者比年轻患者更有可能通过电话就诊而不是视频就诊。远程医疗可用于妇科肿瘤学的各种护理需求，但需要进一步开展工作以优化实施、评估成本效益和患者结局。
